Statistical validation of a threshold to discriminate flow-cytometry minimal residual disease (MRD) levels with prognostic significance in acute myeloid leukemia (AML).

被引：0
|
作者：
Buccisano, Francesco
Maurillo, Luca
Gattei, Valter
Del Poeta, Giovanni
Del Principe, Maria Ilaria
Panetta, Paola
Fraboni, Daniela
Consalvo, Maria Irno
Ottaviani, Licia
Renzi, Daniela
Faccia, Sabrina
Sarlo, Chiara
Lo Coco, Francesco
Amadori, Sergio
Venditti, Adriano
机构：
[1] Policlin Vergata, Rome, Italy
[2] Osped S Eugenio, Rome, Italy
[3] Ctr Riferimento Oncol, Clin & Expt Hematol Res Unit, IRCCS, I-33081 Aviano, Italy
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2299.2299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2299
引用
收藏
页码：651A / 652A
页数：2
相关论文
共 50 条
  • [31] Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiative
    Buecklein, V. L.
    Krause, S.
    Oelschlaegel, U.
    Koehnke, T.
    Schnorfeil, F.
    Voelkl, S.
    Rieger, M. A.
    Berg, T.
    Hoffmann, J.
    Brendel, C.
    Hiddemann, W.
    Subklewe, M.
    von Bonin, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 43 - 43
  • [32] Prognostic Significance of Detection of Minimal Residual Disease by Multiparametric Flow Cytometry Before Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Panitsas, Fotios P.
    Baltathakis, Ioannis
    Kakkas, Ioannis
    Gigantes, Stavros
    Komitopoulou, Anna
    Oikonomopoulos, Panagiotis
    Tzannou, Ifigeneia
    Grigoriou, Eirini
    Balta, Artemisia
    Vourtsi, Aliki
    Skertsou, Maria
    Apostolidis, John
    Psarra, Aikaterini
    Papasteriades, Chryssa
    Karakassis, Dimitrios
    Harhalakis, Nikolaos
    BLOOD, 2011, 118 (21) : 1759 - 1759
  • [33] Minimal residual disease in acute myeloid leukemia in children: MRD-AML-BFM 98 working group
    Griesinger, F
    Langebrake, C
    Dworzak, M
    Hrusak, O
    Viehmann, S
    Creutzig, U
    Harbott, J
    Reinhardt, D
    BLOOD, 2001, 98 (11) : 584A - 584A
  • [34] The Clinical Significance of Minimal Residual Disease Detected By Multiparametric Flow Cytometry in Acute Leukemia
    Huang, Fen
    Jing, Hui
    Yi, Zhengshan
    Wei, Xiaolei
    Zheng, Zhongxin
    Xie, Muchen
    Feng, Ru
    BLOOD, 2014, 124 (21)
  • [35] Minimal residual disease monitoring by four color flow cytometry before second induction is an independent prognostic factor in childhood acute myeloid leukemia - AML-BFM MRD study group.
    Langebrake, C
    Dworzak, M
    Hrusak, O
    Mejstrikova, E
    Griesinger, F
    Zimmermann, M
    Creutzig, U
    Reinhardt, D
    BLOOD, 2005, 106 (11) : 198A - 198A
  • [36] Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
    Ravandi, Farhad
    Jorgensen, Jeffrey
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Pierce, Sherry
    Brandt, Mark
    Wang, Sa
    Konoplev, Sergej
    Wang, Xuemei
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2017, 123 (03) : 426 - 435
  • [37] Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 117A - 117A
  • [38] Prognostic impact of minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) with mutated NPM1: Results of the AML study group (AMLSG)
    Kroenke, J.
    Schlenk, R. F.
    Jensen, K-O
    Eiwen, K.
    Onken, S.
    Habdank, M.
    Spaeth, D.
    Krauter, J.
    Ganser, A.
    Goehring, G.
    Schlegelberger, B.
    Luebbert, M.
    Wattad, M.
    Kindler, T.
    Salih, H. R.
    Mergenthaler, H-G
    Goetze, K.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2010, 33 : 136 - 136
  • [39] Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia.
    Buccisano, Francesco
    Maurillo, Luca
    Gattei, Valter
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Fraboni, Fraboni
    Panetta, Paola
    Consalvo, Maria Irno
    Campagna, Selenia
    Gianni, Laura
    Ottaviani, Licia
    Postorino, Massimiliano
    De Fabritiis, Paolo
    Arcese, William
    Lo Coco, Francesco
    Amadori, Sergio
    Venditti, Adriano
    BLOOD, 2006, 108 (11) : 184A - 184A
  • [40] Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Adult Patients with Acute Myeloid Leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Del Poeta, Giovanni
    Gattei, Valter
    Amadori, Sergio
    Venditti, Adriano
    HAEMATOLOGICA, 2006, 91 : 157 - 157
12345